跳至主要内容
临床试验/NCT07068061
NCT07068061尚未招募不适用

Evaluation of the Performance and Safety of Polydioxanone Suture (PDO) "Bio Meyisun" for the Temporary Correction of the Mid-face Area.

21 Century Medical Co., Ltd.0 个研究点目标入组 50 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
主要终点
The assessment of improvement in mid-face appearance.

研究概览

简要总结

This clinical investigation aims to confirm the safety and efficacy of the ID in facial soft tissue reconstruction, specifically for non-incision surgery to tighten and lift the facial skin for a rejuvenated facial appearance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over 18 years old with full legal capacity, male and female;
  • Patients with ability to understand the proposed aesthetic correction and to understand and sign informed consent;
  • Patients who are willing and able to comply with scheduled visits, aesthetic correction procedure and other trial procedures.

排除标准

  • Pregnant or breast--feeding women;
  • Patients currently participating in any other clinical investigation;
  • Patients who have received a vaccine within 14 days prior to the baseline or plan to have vaccine within 14 days after the injection;
  • Patients with a medical history of systemic diseases, including severe kidney, liver, heart and neurological disorders.

结局指标

主要结局

The assessment of improvement in mid-face appearance.

时间窗: up to 24 weeks

Proportion of subjects with any improvement compared to baseline, as assessed by the Independend Evaluator (IE).

次要结局

  • Further evaluation of improvement of the mid-face appearance.(up to 35 weeks)
  • Self-evaluation of improvement of the mid-face appearance by the Subject.(up to 35 weeks)
  • Number of (S)AEs.(up to 35 weeks)

研究者

发起方
21 Century Medical Co., Ltd.
申办方类型
Industry
责任方
Sponsor

相似试验